Ingenia Therapeutics Inc. (KOSDAQ: A950260)
Health Care · Biotechnology · US
₩24,400.00
+32.11% today · +35.6% 1Y
Ingenia Therapeutics Inc. (KOSDAQ: A950260) operates in the Biotechnology industry within the Health Care sector. The company is valued at $883.30M.
Over the last twelve months the share price has gained 35.6%, trading between 9.90K and 24.75K.
Tweenvest scores Ingenia Therapeutics Inc. across four factors: quality 56/100, value 73/100. Its strongest factor is value.
A950260 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $883.30M
- Revenue (TTM)
- $4.79M
- P/E
- —
- EPS
- -807.42
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩24,750.00
- 52-week low
- ₩9,900.00
- Avg volume (3M)
- —
- Shares outstanding
- 49.44M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jade Biosciences, Inc.NasdaqCM: JBIO | $917.07M | $14.12 | -2.08% |
| Corvus Pharmaceuticals, Inc.NasdaqGM: CRVS | $916.92M | $10.90 | -0.27% |
| Monte Rosa Therapeutics, Inc.NasdaqGS: GLUE | $895.79M | $10.50 | -6.75% |
| Arbutus Biopharma CorporationNasdaqGS: ABUS | $884.38M | $4.45 | -0.45% |
| Rigel Pharmaceuticals, Inc.NasdaqGS: RIGL | $880.76M | $47.15 | +0.38% |
| PeptiDream Inc.TSE: 4587 | $877.11M | ¥1,076.00 | -5.03% |
| Lepu Biopharma Co., Ltd.SEHK: 2157 | $872.98M | HK$3.80 | -6.53% |
| Oxford Biomedica plcLSE: OXB | $871.14M | £5.44 | +7.30% |
Figures last refreshed Sep 27, 2026.